Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
D000818:Animals; D001775:Blood Circulation / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D002302:Cardiac Output / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects*; D006439:Hemodynamics; D006452:Hemoglobinometry; D007545:Isoproterenol / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood*; D010101:Oxygen Consumption / Q000187:drug effects*; D010293:Pargyline / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects*
D010293:Pargyline; D007545:Isoproterenol; D010100:Oxygen